Default company panoramic image

Redox Biocat LLC

Simplifying Human Liver Drug Metabolite Production Using SDP (Stable Dry Powder) Technology: Easier, Faster, Scalable, Cost Effective

  • Stage Product In Development
  • Industry Biotechnology
  • Location Coralville, IA, USA
  • Currency USD
  • Founded June 2013
  • Website

Company Summary

The company produces Stable Dry Powder (SDP) of human liver enzymes for synthesis of drug metabolites. SDP can be produced in Kilograms. Human drug metabolite production is fast, 2-10+ or 100+ mg. Purification of metabolites is easy. Typically a midsize pharmaceutical company makes 2-10 mg of metabolites from 1000+ compounds/year. Metabolite (100+ mg) is also needed for safety studies. Using human liver preparations for this is expensive.


  • Default avatar
    Venkiteswaran (Mani) Subramanian
    Founder & Chief Technology Officer

    Professor, U Iowa 2005-present (50%).
    Global R&D Director, Dow Chemical, 99-05.
    Sr. Leader, Maxygen, 98-99
    Sr. Leader, Sandoz/Novartis 91-98
    Over 70+ publications in scientific journals.
    Over 20 patents
    2013 U of Iowa Research Foundation (UIRF) start up award.
    2013 UIRF innovation award
    2010 Special innovation award from Dow Chemical Company for taking Pfenex, a protein production technology from concept to market.
    Special Dow stock awar

  • Default avatar
    John Serbin
    Business Advisor

    Chief Business Officer, iDiverse, CA
    Chief Business Officer, IDEN, CA

  • Default avatar
    Paul Dymerski
    Business Advisor

    Small Business Advisor, U of Iowa Research Foundation